These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31683923)

  • 1. The
    Berry JL; Polski A; Cavenee WK; Dryja TP; Murphree AL; Gallie BL
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Promoting regulated gene diagnosis for retinoblastoma in clinical work].
    Liang JH; Zhu XM
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):806-810. PubMed ID: 31715676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB1: a prototype tumor suppressor and an enigma.
    Dyson NJ
    Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cordier F; Creytens D
    J Clin Pathol; 2024 Jun; 77(7):435-438. PubMed ID: 38772617
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
    Indovina P; Pentimalli F; Conti D; Giordano A
    Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human retinoblastoma susceptibility gene (RB1): an evolutionary story in primates.
    Viana MC; Tavares WC; Brant AC; Boroni M; Seuánez HN
    Mamm Genome; 2017 Jun; 28(5-6):198-212. PubMed ID: 28401291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
    Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Retinoblastoma.
    Mallipatna A; Marino M; Singh AD
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):260-4. PubMed ID: 27488068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic).
    Reddy MA; Butt M; Hinds AM; Duncan C; Price EA; Sagoo MS; Onadim Z
    Ophthalmol Retina; 2021 Apr; 5(4):381-387. PubMed ID: 32835838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
    Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
    Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
    Menges J; Cremanns M; Steenpass L
    Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.